Dual activity of amphiphilic Zn(II) nitroporphyrin derivatives as HIV-1 entry inhibitors and in cancer photodynamic therapy-Reference-Cited by-同舟云学术

Dual activity of amphiphilic Zn(II) nitroporphyrin derivatives as HIV-1 entry inhibitors and in cancer photodynamic therapy

Published:2019-07 Issue: Volume:174 Page:66-75
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Sengupta Devashish^ORCID,Timilsina Uddhav,Mazumder Zeaul Hoque,Mukherjee Avinaba,Ghimire Dibya,Markandey Manasvini,Upadhyaya Kalpana,Sharma Debdulal,Mishra Nawneet,Jha Tarun^ORCID,Basu Samita,Gaur Ritu

Funder

DBT

DBT-Twinning Project

Government of India

Ministry of Science and Technology

Department of Biotechnology

MANF

SERB

Department of Science and Technology and South Asian University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference45 articles.

1. Photodynamic therapy for cancer;Dolmans;Nat. Rev. Canc.,2003

2. How does photodynamic therapy work?;Henderson;Photochem. Photobiol.,1992

3. The Porphyrin Handbook;Kadish,2000

4. Photodynamic therapy systems and applications;Marcus;Expert Opin. Emerg. Drugs,2002

5. Enhanced cellular uptake with a Cobaltacarborane−Porphyrin−HIV-1 Tat 48−60 conjugate;Sibrian-Vazquez;Bioconjug. Chem.,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insights and photophysical properties of mononuclear and pentanuclear Zn(II) acetate complexes with pyridyl-based thiazolyl-hydrazones;Polyhedron;2024-11

2. Repurposing anti-cancer porphyrin derivative drugs to target SARS-CoV-2 envelope;Biomedicine & Pharmacotherapy;2024-07

3. Photo-activated Efficacy Against HIV-1, Multiple Microbes and Biofilms by Zinc-complexes of Combinations of Cationic Ammoniumphenyl and Methylpyridinium-Porphyrins;2024-05-06

4. Porphyrins with combinations of 4-carboxyphenyl and 4-hydroxyphenyl substituents in meso-positions as anti-HIV-1 agents;Scientific Reports;2024-05-01

5. Combinations of meso-(4-carboxyphenyl) and meso-(4- hydroxyphenyl) porphyrins as anti-HIV-1 agents;2024-03-06